Heparin use in children

Pediatric Research

Volumn 61, Issue 2, 2007, Pages 139-140

  Young, Guy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; GLYCOSAMINOGLYCAN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PENTASACCHARIDE; THROMBIN;

ANTICOAGULANT THERAPY; BLEEDING; DRUG BINDING; DRUG EFFECT; DRUG FORMULATION; DRUG OVERDOSE; DRUG USE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTRAVASCULAR CATHETER; MEDICAL ERROR; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CONFORMATION;

ANTICOAGULANTS; CHILD; HEPARIN; HUMANS; INFANT, NEWBORN; RISK ASSESSMENT; THROMBOCYTOPENIA;

EID: 33846413545     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/pdr.0b013e318031d4d1     Document Type: Note

References (2)

1. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD 2004 Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:645S-687S
2. Shah P, Shah V 2005 Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database Syst Rev 2005 Jul 20:CD00277